Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.3 is added to the study's history and the previous revision v3.5.2 is removed from the current history view, updating the version history record.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Revision: v3.5.2 to the history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.4.3; Removed Revision: v3.4.2.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.2 was added to the history. The older operating-status notice (v3.4.1) was removed.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a site-wide notice about government funding and status updates with links to cc.nih.gov and opm.gov, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.